A portable, versatile and low-cost molecular detection tool being developed by a team of European researchers promises to revolutionise the diagnosis of diseases such as cancer and open up new applications in sectors as diverse as environmental protection, chemical analysis and food safety.
Working in the field of micro- and nano-technologies, the IST programme-funded BioFinger project is due to begin testing its state-of-the-art system over the summer amid expectations for a commercial product to be available on the market within two to three years.
“What we are creating is a generic, highly precise and highly versatile tool to detect and analyse molecules in the blood and other fluids using nano and micro cantilevers,” explains project coordinator Joan Bausells at the Consejo Superior de Investigaciones Cientificas in Spain.
Nanocantilevers, smaller than the surface of a fly’s eye, and their larger counterparts microcantilevers, function as sensors to detect molecules providing in the medical world, for example, a way to rapidly and accurately diagnose disease. When coated with antibodies they bend and resonate to changes in surface tension and mass when fluids containing disease-related protein molecules attach to them. By seeing whether or not the cantilevers react, doctors would be able to determine whether or not a disease is present.
Though much research has been carried out into cantilevers, it has focused principally on creating large-scale tools for use inside laboratories.
“You can’t carry those around with you, so what we are developing is the first portable device that will allow doctors to diagnose diseases on the spot almost immediately,” Bausells says.
During trials at Cork University Hospital in Ireland this summer, the microcantilever version of the system will be used to detect a protein associated with prostate cancer, while the nanocantilever system, which can detect a single molecule, will be used to test blood samples for interleukin 6, a protein associated with inflammation.
The BioFinger tool incorporates the cantilevers on a microchip that is disposable after each use, allowing it to be reconfigured with new on-chip cantilevers to detect different substances. The analysis, which can be performed anywhere, anytime, takes between 15 and 20 minutes, “considerably less than the hours or days” it takes to analyse a blood sample using traditional in-lab methods, the coordinator notes. In addition, the system is likely to be considerably cheaper than traditional diagnosis techniques with each disposable chip expected to cost around 8 euros.
“It is also extremely versatile,” Bausells notes. “It could be used to detect virtually any disease, as a pregnancy test or even to determine blood types. Outside of the medical field, it could be used to analyse chemicals, detect bacteria in food or test for water pollution.”
Tara Morris | alfa
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine